跳轉至內容
Merck
  • Dominant KPNA3 Mutations Cause Infantile-Onset Hereditary Spastic Paraplegia.

Dominant KPNA3 Mutations Cause Infantile-Onset Hereditary Spastic Paraplegia.

Annals of neurology (2021-09-27)
Claudia Schob, Maja Hempel, Dana Safka Brozkova, Huafang Jiang, Soo Yeon Kim, Nurit Assia Batzir, Naama Orenstein, Tatjana Bierhals, Jessika Johannsen, Anna Uhrova Meszarosova, Jong-Hee Chae, Pavel Seeman, Mathias Woidy, Fang Fang, Christian Kubisch, Stefan Kindler, Jonas Denecke
摘要

Hereditary spastic paraplegia (HSP) is a highly heterogeneous neurologic disorder characterized by lower-extremity spasticity. Here, we set out to determine the genetic basis of an autosomal dominant, pure, and infantile-onset form of HSP in a cohort of 8 patients with a uniform clinical presentation. Trio whole-exome sequencing was used in 5 index patients with infantile-onset pure HSP to determine the genetic cause of disease. The functional impact of identified genetic variants was verified using bioinformatics and complementary cellular and biochemical assays. Distinct heterozygous KPNA3 missense variants were found to segregate with the clinical phenotype in 8 patients; in 4 of them KPNA3 variants had occurred de novo. Mutant karyopherin-α3 proteins exhibited a variable pattern of altered expression level, subcellular distribution, and protein interaction. Our genetic findings implicate heterozygous variants in KPNA3 as a novel cause for autosomal dominant, early-onset, and pure HSP. Mutant karyopherin-α3 proteins display varying deficits in molecular and cellular functions, thus, for the first time, implicating dysfunctional nucleocytoplasmic shuttling as a novel pathomechanism causing HSP. ANN NEUROL 2021;90:738-750.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
抗-β微管蛋白同种型 III 抗体,小鼠单克隆 小鼠抗, clone SDL.3D10, purified from hybridoma cell culture